270
Views
10
CrossRef citations to date
0
Altmetric
Original Article

Protease nexin-1 protects against Alzheimer’s disease by regulating the sonic hedgehog signaling pathway

, &
Pages 1087-1096 | Received 29 Dec 2019, Accepted 07 May 2020, Published online: 09 Jun 2020

References

  • Zhao Y, Cai J, Liu Z, et al. Nanocomposites inhibit the formation, mitigate the neurotoxicity, and facilitate the removal of β-amyloid aggregates in Alzheimer's disease mice. Nano Lett. 2019; 19(2):674–683.
  • Alzheimer’s A. Alzheimer’s disease facts and figures. Alzheimers Dement. 2015;11(3):332–384.
  • Chan KY, Wang W, Wu JJ, Liu L, Theodoratou E, Car J, Middleton L, Russ TC, Deary IJ, Campbell H, et al. Epidemiology of Alzheimer’s disease and other forms of dementia in China, 1990-2010: a systematic review and analysis. Lancet. 2013; 381(9882):2016–2023.
  • Zhang Z, Yang J, Liu C, et al. Pseudoginsenoside-F11 alleviates cognitive deficits and Alzheimer's disease-type pathologies in SAMP8 mice . Pharmacol Res. 2019; 139:512–523.
  • Yuan C, Guo X, Zhou Q, et al. OAB-14, a bexarotene derivative, improves Alzheimer's disease-related pathologies and cognitive impairments by increasing β-amyloid clearance in APP/PS1 mice . Biochim Biophys Acta Mol Basis Dis. 2019; 1865(1):161–180.
  • Jia J, Wei C, Chen S, et al. The cost of Alzheimer's disease in China and re-estimation of costs worldwide . Alzheimers Dement. 2018; 14(4):483–491.
  • Li F, Chen S, Wei C, et al. Monetary costs of Alzheimer's disease in China: protocol for a cluster-randomised observational study . BMC Neurol. 2017; 17(1):15
  • Yang Y, Xin X, Fu X, et al. Expression pattern of human SERPINE2 in a variety of human tumors. Oncol Lett. 2018; 15(4):4523–4530.
  • Pagliara V, Adornetto A, Mammi M, et al. Protease Nexin-1 affects the migration and invasion of C6 glioma cells through the regulation of urokinase Plasminogen Activator and Matrix Metalloproteinase-9/2. Biochim Biophys Acta. 2014; 1843(11):2631–2644.
  • Mirante O, Price M, Puentes W, et al. Endogenous protease nexin-1 protects against cerebral ischemia. Int J Mol Sci. 2013; 14(8):16719–16731.
  • Wagner SL, Geddes JW, Cotman CW, et al. Protease nexin-1, an antithrombin with neurite outgrowth activity, is reduced in Alzheimer disease. Proc Natl Acad Sci USA. 1989; 86(21):8284–8288.
  • Vaughan PJ, Su J, Cotman CW, et al. Protease nexin-1, a potent thrombin inhibitor, is reduced around cerebral blood vessels in Alzheimer’s disease. Brain Res. 1994; 668(1-2):160–170.
  • Vaillant C, Valdivieso P, Nuciforo S, et al. Serpine2/PN-1 Is Required for Proliferative Expansion of Pre-Neoplastic Lesions and Malignant Progression to Medulloblastoma. PloS ONE. 2015; 10(4):e0124870
  • Xin X, Ding Y, Yang Y, et al. Protease nexin-1 prevents growth of human B cell lymphoma via inhibition of sonic hedgehog signaling. Blood Cancer J. 2018; 8(2):24
  • McKee CM, Xu D, Cao Y, et al. Protease nexin 1 inhibits hedgehog signaling in prostate adenocarcinoma. J Clin Invest. 2012; 122(11):4025–4036.
  • Hung YH, Chang SH, Huang CT, et al. Inhibitor of Differentiation-1 and Hypoxia-Inducible Factor-1 Mediate Sonic Hedgehog Induction by Amyloid Beta-Peptide in Rat Cortical Neurons. Mol Neurobiol. 2016; 53(2):793–809.
  • He P, Staufenbiel M, Li R, et al. Deficiency of patched 1-induced Gli1 signal transduction results in astrogenesis in Swedish mutated APP transgenic mice. Hum Mol Genet. 2014; 23(24):6512–6527.
  • Ma J, Gao Y, Jiang L, et al. Fluoxetine attenuates the impairment of spatial learning ability and prevents neuron loss in middle-aged APPswe/PSEN1dE9 double transgenic Alzheimer's disease mice. Oncotarget. 2017; 8(17):27676–27692.
  • Sun Y, Zhang JR, Chen S. Suppression of Alzheimer’s disease-related phenotypes by the heat shock protein 70 inducer, geranylgeranylacetone, in APP/PS1 transgenic mice via the ERK/p38 MAPK signaling pathway. Exp Ther Med. 2017; 14(6):5267–5274.
  • Orlans FB. Ethical decision making about animal experiments. Ethics Behav. 1997; 7(2):163–171.
  • Yao ZG, Zhang L, Liang L, et al. The effect of PN-1, a traditional Chinese prescription, on the learning and memory in a transgenic mouse model of Alzheimer’s disease. Evidence-Based Complementary Altern Med. 2013; 2013:1–12.
  • Xia H, Wu L, Chu M, et al. Effects of breviscapine on amyloid beta 1–42 induced Alzheimer's disease mice: A HPLC-QTOF-MS based plasma metabonomics study. J Chromatogr B Analyt Technol Biomed Life Sci. 2017; 1057:92–100.
  • Zhang C, Xie L, Guan F, et al. 3H-1,2-dithiole-3-thione protects PC12 cells against amyloid beta 1–42 (Aβ1–42) induced apoptosis via activation of the ERK1/2 pathway. Life Sci. 2018; 213:74–81.
  • Koh EJ, Kim KJ, Choi J, et al. Spirulina maxima extract prevents cell death through BDNF activation against amyloid beta 1–42 (Aβ1–42) induced neurotoxicity in PC12 cells. Neurosci Lett. 2018; 673:33–38.
  • Smith-Swintosky VL, Zimmer S, Fenton JW, 2nd, et al. Opposing actions of thrombin and protease nexin-1 on amyloid beta-peptide toxicity and on accumulation of peroxides and calcium in hippocampal neurons. J Neurochem. 1995;65(3):1415–1418. :
  • Sun L, Guo C, Liu D, et al. Protective effects of bone morphogenetic protein 7 against amyloid-beta induced neurotoxicity in PC12 cells. Neuroscience. 2011; 184:151–163.
  • Lee MH, Shih YH, Lin SR, et al. Zfra restores memory deficits in Alzheimer's disease triple-transgenic mice by blocking aggregation of TRAPPC6AΔ, SH3GLB2, tau, and amyloid β, and inflammatory NF-κB activation . Alzheimers Dement (N Y)). 2017; 3(2):189–204.
  • Lino MM, Atanasoski S, Kvajo M, et al. Mice lacking protease nexin-1 show delayed structural and functional recovery after sciatic nerve crush. J Neurosci. 2007; 27(14):3677–3685.
  • Azoulay S, Terry S, Chimingqi M, et al. Comparative expression of Hedgehog ligands at different stages of prostate carcinoma progression. J Pathol. 2008; 216(4):460–470.
  • Kumaran A, Ho CC, Hwang LS. Protective effect of Nelumbo nucifera extracts on beta amyloid protein induced apoptosis in PC12 cells, in vitro model of Alzheimer's disease. J Food Drug Anal. 2018; 26(1):172–181.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.